scorecardresearchDivis Laboratories Share Price Live NSE, BSE, Today - Divis Laboratories Stock Price

Divis Laboratories

BSE: 532488 | NSE: DIVISLAB | ISIN: INE361B01024 | SECTOR: Biotechnology & Drugs

3,317.45 -49.90 (-1.48%)

31 Jan 2023, 10:11 (IST)
  • Open

    3,367.55
  • High

    3,379.80
  • Low

    3,310.00
  • Prev Close

    3,367.35
  • P/E

    -
  • Median P/E

    -
  • P/B

    -
  • Median P/B

    -
  • Market Cap

    -
  • Volume

    10.01K
  • Vol. (20 day Avg.)

    0
  • PEG

    -
  • Div.Yield

    -
  • Bid

    3,322.00
  • Ask

    -

Company Description

  • Biotechnology & Drugs
  • BSE

    532488
  • NSE

    DIVISLAB
  • ISIN

    INE361B01024

Divi's Laboratories Limited is an India-based company, which is engaged in manufacturing and sale of active pharmaceutical ingredients (APIs), intermediates and nutraceutical ingredients with predominance in exports. The Company’s products include Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextromethorphan HBr, Gabapentin, Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam, Levodopa, Losartan, Nabumetone, Naproxen, Naproxen Sodium, Olmesartan Medoxomil, Pregabalin, Ticagrelor, Triprolidine HCl, Valacyclovir HCl, Valsartan, Venlafaxine HCl and Vigabatrin. The Company’s subsidiaries include Divi’s Laboratories USA, Inc., (Divi’s USA) and Divi’s Laboratories Europe AG (Divi’s Europe).

Company Officers

  • Kiran Divi

    Chief Executive Officer, Whole-time Director
  • L. Kishore Babu

    Chief Financial Officer
  • M. Satish Choudhury

    Chief Compliance Officer, Company Secretary
  • Murali Divi

    Managing Director, Executive Director
  • Madhusudana Divi

    Whole-Time Director (Projects)
  • Nilima Divi

    Whole-Time Director (Commercial)
  • Nimmagadda Ramana

    Executive Director